Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Marker Therapeutics, Inc. - Common Stock (NQ:MRKR)

1.475 +0.025 (+1.72%)
Streaming Delayed Price Updated: 12:33 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Marker Therapeutics, Inc. - Common Stock

News headline image
Earnings Scheduled For May 12, 2021 ↗
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Motus GI Hldgs (NASDAQ:MOTS) stock increased by 46.78% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $74.7... 
Via Benzinga
News headline image
25 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares rose 42% to $3.99 in pre-market trading after the company said its electronics unit has won a contract for deep space program... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Assertio Holdings (NASDAQ:ASRT) stock increased by 19.41% to $0.62 during Thursday's pre-market session. The company's market cap stands at $107.3 million... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.